ClinicalTrials.gov
public full text
Public Domain
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia
acute-lymphoblastic-leukemiaacute-myeloid-leukemiab-cell-non-hodgkin-lymphomachronic-lymphocytic-leukemia
This pilot clinical trial compares the safety of two different platelet transfusion "thresholds" among patients with blood cancer or treatment-induced thrombocytopenia whose condition requires anticoagulant medication (blood thinners) for blood clots. Giving relatively fewer platelet transfusions may reduce the side effects of frequent platelet transfusions without leading to undue bleeding.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The impact of patient ethnicity on cancer incidence following platelet count and C-reactive protein tests in English primary care: a cohort study of 5 million patients#424615
- Circulating Tumor Cell Genome in Peripheral Blood From Hepatocellular Carcinoma Patients Under Radiotherapy#1182333
- Feasibility of a New Technology for Isolating Circulating Tumour Cells#884624
- Studies on human blood platelets#1298763
- Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study)#1007983
Record · ID 1452512
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive